cDCs, due to their normal distribution in peripheral blood, the lymphatic system, and tissues, have a superior ability in capturing tumor-associated antigens, cross-presenting exogenous antigens on MHC-I, migrate normally to lymph nodes to start an interaction with naïve T cells, and cross-present antigens to activate CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.